Neurobiological Technologies Alpha and Beta Analysis
| NTIIDelisted Stock | USD 0.0001 0.00 0.00% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Neurobiological Technologies. It also helps investors analyze the systematic and unsystematic risks associated with investing in Neurobiological Technologies over a specified time horizon. Remember, high Neurobiological Technologies' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Neurobiological Technologies' market risk premium analysis include:
Beta 0.0 | Alpha 0.0 | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Neurobiological |
Neurobiological Technologies Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Neurobiological Technologies market risk premium is the additional return an investor will receive from holding Neurobiological Technologies long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Neurobiological Technologies. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Neurobiological Technologies' performance over market.| α | 0.00 | β | 0.00 |
Neurobiological Technologies Fundamentals Vs Peers
Comparing Neurobiological Technologies' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Neurobiological Technologies' direct or indirect competition across all of the common fundamentals between Neurobiological Technologies and the related equities. This way, we can detect undervalued stocks with similar characteristics as Neurobiological Technologies or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Neurobiological Technologies' fundamental indicators could also be used in its relative valuation, which is a method of valuing Neurobiological Technologies by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Neurobiological Technologies to competition |
| Fundamentals | Neurobiological Technologies | Peer Average |
| Return On Equity | 1.0 | -0.31 |
| Profit Margin | 0.74 % | (1.27) % |
| Operating Margin | 0.77 % | (5.51) % |
| Current Valuation | (26.24 M) | 16.62 B |
| Shares Outstanding | 27.02 M | 571.82 M |
| Shares Owned By Institutions | 9.41 % | 39.21 % |
| Number Of Shares Shorted | 37.6 K | 4.71 M |
Neurobiological Technologies Opportunities
Neurobiological Technologies Return and Market Media
The Stock received some media coverage during the period. Price Growth (%) |
| Timeline |
1 | Investor weakness and your brain why we sell winners and hold ... - The Australian Financial Review | 04/21/2023 |
2 | New insights into the complex neurochemistry of ants In terms of ... - Science Daily | 05/22/2023 |
3 | Ross A. Hammond Brookings - Brookings Institution | 06/26/2023 |
About Neurobiological Technologies Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Neurobiological or other delisted stocks. Alpha measures the amount that position in Neurobiological Technologies has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Neurobiological Technologies in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Neurobiological Technologies' short interest history, or implied volatility extrapolated from Neurobiological Technologies options trading.
Build Portfolio with Neurobiological Technologies
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Consideration for investing in Neurobiological Stock
If you are still planning to invest in Neurobiological Technologies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Neurobiological Technologies' history and understand the potential risks before investing.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |